Target Name: PIWIL1
NCBI ID: G9271
Review Report on PIWIL1 Target / Biomarker Content of Review Report on PIWIL1 Target / Biomarker
PIWIL1
Other Name(s): piwi like RNA-mediated gene silencing 1 | Piwi-like protein 1 (isoform 2) | piwi homolog | PIWIL1 variant 2 | CT80.1 | PIWIL1 variant 1 | Piwi homolog | Piwi like RNA-mediated gene silencing 1, transcript variant 1 | Piwi-like protein 1 | HIWI | MIWI | PIWL1_HUMAN | Piwi like RNA-mediated gene silencing 1, transcript variant 2 | PIWI | Piwi-like protein 1 (isoform 1)

PIWI1: A Drug Target and Potential Biomarker for Gene Silencing

Introduction

Gene silencing is a critical process in cellular biology, where the expression of specific genes is either turned on or off to maintain tissue homeostasis and physiological functions. PIWI1, also known as RNA-mediated gene silencing 1, is a non-coding RNA molecule that has been extensively studied in various cellular contexts. PIWI1 plays a pivotal role in gene silencing, which is critical for the development and maintenance of normal tissues. In this article, we will discuss PIWI1 as a drug target and potential biomarker.

Drug Target Potential

PIWI1 has been identified as a potential drug target due to its critical role in gene silencing. Several studies have shown that PIWI1 can interact with various protein partners, including histone modifications, non-coding RNAs, and small molecules. These interactions suggest that PIWI1 could be a useful target for therapeutic interventions aimed at modulating gene expression.

One of the key reasons for PIWI1's potential as a drug target is its involvement in the regulation of stem cell proliferation and differentiation. PIWI1 has been shown to play a role in the regulation of the proliferation and self-renewal of stem cells, which are critical for the development of tissues and organs.

In addition, PIWI1 has been linked to the regulation of cell survival and lifespan. Studies have shown that PIWI1 can interact with the protein p53, which is a well-known regulator of DNA damage repair and cell survival. This interaction suggests that PIWI1 may be a potential target for therapies aimed at preventing or treating age-related diseases.

Potential Biomarker

The ability of PIWI1 to be a drug target also makes it an attractive biomarker for assessing the efficacy of potential therapeutic interventions. One of the challenges in the development of new therapies is the lack of effective biomarkers that can predict treatment outcomes. PIWI1 could provide a valuable tool for this purpose, as its expression levels could be easily measured and its function could be targeted using small molecules or other therapeutic approaches.

In addition, PIWI1 has been shown to play a role in the regulation of gene expression in various tissues and organs, which could make it an attractive biomarker for assessing the efficacy of drugs aimed at modulating gene expression. The expression of PIWI1 has been shown to be regulated by various factors, including DNA methylation, histone modifications, and small molecules. This complexity in regulation suggests that PIWI1 could be a challenging target for small molecules, and that its function as a biomarker will require further study.

Conclusion

In conclusion, PIWI1 is a non-coding RNA molecule that plays a critical role in the regulation of gene silencing. Its potential as a drug target and biomarker make it an attractive target for the development of new therapies aimed at modulating gene expression and treating various diseases. Further research is needed to fully understand the role of PIWI1 in gene silencing and its potential as a biomarker for therapeutic interventions.

Protein Name: Piwi Like RNA-mediated Gene Silencing 1

Functions: Endoribonuclease that plays a central role in postnatal germ cells by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Directly binds methylated piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. Strongly prefers a uridine in the first position of their guide (g1U preference, also named 1U-bias). Not involved in the piRNA amplification loop, also named ping-pong amplification cycle. Acts as an endoribonuclease that cleaves transposon messenger RNAs. Besides their function in transposable elements repression, piRNAs are probably involved in other processes during meiosis such as translation regulation. Probable component of some RISC complex, which mediates RNA cleavage and translational silencing. Also plays a role in the formation of chromatoid bodies and is required for some miRNAs stability. Required to sequester RNF8 in the cytoplasm until late spermatogenesis; RNF8 being released upon ubiquitination and degradation of PIWIL1

The "PIWIL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIWIL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1 | PJA1 | PJA2 | PJVK | PKD1 | PKD1-AS1 | PKD1L1 | PKD1L1-AS1 | PKD1L2 | PKD1L3 | PKD1P1 | PKD1P4-NPIPA8 | PKD1P6 | PKD2 | PKD2L1 | PKD2L2 | PKD2L2-DT | PKDCC | PKDREJ | PKHD1 | PKHD1L1 | PKIA | PKIA-AS1 | PKIB | PKIG | PKLR | PKM | PKMP1 | PKMYT1 | PKN1 | PKN2 | PKN2-AS1 | PKN3 | PKNOX1 | PKNOX2 | PKNOX2-DT | PKP1 | PKP2 | PKP3 | PKP4 | PKP4-AS1 | PLA1A | PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D | PLA2G2E | PLA2G2F | PLA2G3 | PLA2G4A | PLA2G4B | PLA2G4C | PLA2G4D | PLA2G4E | PLA2G4F | PLA2G5 | PLA2G6 | PLA2G7 | PLA2R1 | PLAA | PLAAT1 | PLAAT2 | PLAAT3 | PLAAT4 | PLAAT5 | PLAC1 | PLAC4 | PLAC8 | PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1 | PLBD1-AS1 | PLBD2 | PLCB1 | PLCB2 | PLCB3 | PLCB4 | PLCD1